First report of Wilson disease and Bruton agammaglobulinemia in the same patient caused by new mutations in


Journal

Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073

Informations de publication

Date de publication:
2023
Historique:
received: 05 09 2022
accepted: 14 03 2023
medline: 15 5 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: epublish

Résumé

Wilson disease is characterized by an alteration in copper metabolism that causes its accumulation in different tissues. Its diagnosis is established by the combination of clinical manifestations and paraclinical and genetic studies. Bruton agammaglobulinemia is an X-linked recessive hereditary disease belonging to the group of primary immunodeficiencies and is produced by mutation in the A 14-year-old Colombian patient with clinical characteristics of Bruton agammaglobulinemia presented with liver disease and clinically and molecularly diagnosed with Wilson disease. Bruton agammaglobulinemia and Wilson disease are considered rare diseases because of their low prevalence. We report for the first time a pediatric patient from southwestern Colombia presenting with both entities, and diagnosed clinically and molecularly, an association so far not reported in the literature.

Identifiants

pubmed: 37169567
doi: 10.15586/aei.v51i3.770
doi:

Substances chimiques

Agammaglobulinaemia Tyrosine Kinase EC 2.7.10.2
Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-110

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

1. Roberts EA, Socha P. Wilson’s disease in children. Handb Clin Neurol. 2017;142:141–156. 10.1016/B978-0-444-63625-6.00012-4
doi: 10.1016/B978-0-444-63625-6.00012-4
2. Pfeiffer RF. Wilson’s disease. Continuum (Minneap Minn). 2016; 22(4 (Movement Disorders):1246–1261. 10.1212/CON.0000000000000350
doi: 10.1212/CON.0000000000000350
3. Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson’s disease: An update. Hepatology. 2019;71(2):722–732. 10.1002/hep.30911
doi: 10.1002/hep.30911
4. Ferenci P. Diagnosis of Wilson disease. Handb Clin Neurol. 2017;142:171–180. 10.1016/B978-0-444-63625-6.00014-8
doi: 10.1016/B978-0-444-63625-6.00014-8
5. Eda K, Mizuochi T, Iwama I, Inui A, Etani Y, Araki M, et al. Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan. J Gastroenterol Hepatol. 2018;33(1):264–269. 10.1111/jgh.13812
doi: 10.1111/jgh.13812
6. Sharma D, Gupta A, Goel S, Sharma M, Rawat A, Singh S. Large BTK gene mutation in a child with X-linked agammaglobulinemia and polyarthritis. Clin Immunol. 2017;183:109–111. 10.1016/j.clim.2017.08.005
doi: 10.1016/j.clim.2017.08.005
7. Shillitoe B, Gennery A. X-linked agammaglobulinaemia: Outcomes in the modern era. Clin Immunol. 2017;183:54–62. 10.1016/j.clim.2017.07.008
doi: 10.1016/j.clim.2017.07.008
8. Suri D, Rawat A, Singh S. X-linked Agammaglobulinemia. Indian J Pediatr. 2016;83(4):331–337. 10.1007/s12098-015-2024-8
doi: 10.1007/s12098-015-2024-8
9. Corneth OBJ, Klein Wolterink RGJ, Hendriks RW. BTK Signaling in B Cell Differentiation and Autoimmunity. Curr Top Microbiol Immunol. 2016;393:67–105. 10.1007/82_2015_478
doi: 10.1007/82_2015_478
10. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9(6):722–728. 10.1542/peds.9.6.722
doi: 10.1542/peds.9.6.722
11. Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000;19(2):183–204. 10.1385/CRIAI:19:2:183
doi: 10.1385/CRIAI:19:2:183
12. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. Standards and guidelines for the interpretation of sequence variants a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–424. 10.1038/gim.2015.30
doi: 10.1038/gim.2015.30
13. National Center for Biotechnology Information. ClinVar. 2017; Accession: VCV000456553.6. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000456553.6

Auteurs

Manuela Olaya-Hernandez (M)

Department of Allergology, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.
Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia; manuela.olaya@fvl.org.co.

Carolina Aristizábal-Henao (C)

Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia.

Paola Perez-Camacho (P)

Pediatrics Department, Infectology Service and Hematoncological Transplant Service, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Jaime Patiño-Niño (J)

Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Pediatrics Department, Infectology Service, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Diego Medina-Valencia (D)

Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Pediatrics Department, Gastroenterology and Hepatology Service, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Veronica Botero-Osorio (V)

Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Department of Gastroenterology, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Harry Pachajoa (H)

Faculty of Health Sciences, Universidad Icesi, Cali, Valle del Cauca, Colombia.
Pediatrics Department, Clinical Genetics Service, Fundación Valle del Lili, Cali, Valle del Cauca, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH